Galletta Christopher 4
4 · Trevi Therapeutics, Inc. · Filed Dec 3, 2025
Insider Transaction Report
Form 4
Galletta Christopher
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2025-12-02$0.51/sh+4,225$2,159→ 26,095 total - Exercise/Conversion
Stock Option (right to buy)
2025-12-02−4,225→ 15,775 totalExercise: $0.51Exp: 2032-02-10→ Common Stock (4,225 underlying)
Footnotes (2)
- [F1]Includes 6,870 shares purchased through the Issuer's employee stock purchase plan.
- [F2]This option was granted on February 11, 2022. The 35,000 shares of common stock underlying the option vested as to 25% of the shares on February 11, 2023 and vest as to the remaining 75% of the shares in equal monthly installments thereafter through February 11, 2026.